For an 85‑kg patient with a creatinine clearance of 24 mL/min, what loading dose (mg/kg) and maintenance dose (mg/kg once daily) should be administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Weight-Based Vancomycin Dosing in Severe Renal Impairment

For an 85-kg patient with a creatinine clearance of 24 mL/min, administer a loading dose of 20 mg/kg (1700 mg) followed by a maintenance dose of approximately 7-8 mg/kg once daily (600 mg every 24 hours), with mandatory therapeutic drug monitoring before the fourth dose to adjust for individual pharmacokinetics.

Rationale for Loading Dose

The loading dose should be 20 mg/kg based on actual body weight regardless of renal function 1. This translates to approximately 1700 mg for an 85-kg patient. The 2009 IDSA/ASHP/SIDP guidelines explicitly state that vancomycin dosages of 15-20 mg/kg are required for most patients, and this loading dose is critical to rapidly achieve therapeutic concentrations 1.

  • Loading doses are not adjusted for renal dysfunction because they depend on volume of distribution, not clearance
  • Recent research confirms that higher loading doses (up to 35 mg/kg in critically ill patients) may be necessary to rapidly achieve target concentrations 2
  • For your 85-kg patient: 20 mg/kg × 85 kg = 1700 mg loading dose

Rationale for Maintenance Dose

Maintenance dosing must be substantially reduced in severe renal impairment (CrCl 24 mL/min). While the guidelines recommend 15-20 mg/kg every 8-12 hours for normal renal function 1, your patient requires dramatic dose reduction:

Calculation Approach:

Using the established relationship between vancomycin clearance and creatinine clearance 3:

  • Dose (mg/kg/24h) = 0.227 × CrCl + 5.67 (where CrCl is standardized to mL/min per 70 kg)
  • For CrCl 24 mL/min: Dose = 0.227 × 24 + 5.67 = 11.1 mg/kg per 24 hours
  • For 85-kg patient: 11.1 × 85 = 944 mg per 24 hours

However, this formula was developed before AUC-targeted dosing. A more conservative approach of 7-8 mg/kg once daily (approximately 600 mg every 24 hours) is safer initially, with dose adjustment based on therapeutic drug monitoring.

Dosing Interval:

With CrCl 10-24 mL/min, the appropriate interval is every 24 hours 3. Some sources suggest extending to 48 hours for CrCl <10 mL/min, but at 24 mL/min, once-daily dosing is appropriate.

Critical Monitoring Requirements

Measure trough concentration before the fourth dose (steady state) 1:

  • Target trough: 15-20 mg/L for serious infections (bacteremia, endocarditis, osteomyelitis, pneumonia, meningitis)
  • Target trough: 10-15 mg/L for less severe infections
  • This patient is at high risk for nephrotoxicity given pre-existing renal impairment

Nephrotoxicity Monitoring:

Monitor serum creatinine closely. Vancomycin-induced nephrotoxicity is defined as ≥2-3 consecutive increases in creatinine of 0.5 mg/dL or ≥50% from baseline after several days of therapy 1.

Important Caveats

Infusion Rate:

When individual doses exceed 1 g (as with your 1700 mg loading dose), extend infusion time to 1.5-2 hours to reduce risk of red man syndrome 1.

AUC/MIC Targeting:

The guidelines recommend targeting AUC/MIC ≥400 for optimal efficacy 1. With severe renal impairment, achieving this target while avoiding toxicity requires:

  • Aggressive initial dosing (hence the full loading dose)
  • Conservative maintenance dosing
  • Early therapeutic drug monitoring
  • Potential dose adjustments based on measured levels

Alternative Considerations:

If the vancomycin MIC is ≥2 mg/L, alternative therapies should be considered as target AUC/MIC is not achievable with conventional dosing in renal impairment 1.

Practical Summary

Loading Dose: 1700 mg IV over 1.5-2 hours
Maintenance Dose: 600 mg IV every 24 hours (approximately 7 mg/kg/day)
First Monitoring: Trough level before 4th dose
Adjust: Based on trough levels and renal function changes

This conservative approach prioritizes avoiding nephrotoxicity in a patient with already compromised renal function while ensuring adequate initial exposure through appropriate loading.

Related Questions

What is the appropriate vancomycin dosing regimen for a patient with sepsis, including loading dose and maintenance adjustments based on renal function?
What is the appropriate vancomycin dosing regimen for an 81‑lb (approximately 37 kg) patient?
What is the appropriate drug dosing for an adult with a solitary kidney and normal renal function?
What is the appropriate intravenous vancomycin dosing for a 170‑lb (≈77 kg) diabetic nursing‑home resident with severe leg cellulitis?
What is the appropriate vancomycin dosing regimen for an 80-year-old patient with a serum creatinine of 3.5 mg/dL?
What is the appropriate vancomycin dosing for bacteremia in a patient weighing 85 kg with a creatinine clearance of 24 mL/min?
Given an arterial blood gas with pH 7.33, PaCO2 44 mm Hg, PaO2 173 mm Hg, bicarbonate 22.3 mmol/L, and base excess –3, what is the interpretation and recommended management?
In a patient with recent melena from a bleeding duodenal ulcer who is on clopidogrel (Plavix), has atrial fibrillation, and has been treated with blood transfusions and a proton pump inhibitor (PPI), can clopidogrel be stopped and a direct oral anticoagulant (DOAC) started, and which DOAC and reduced dose are appropriate for an elevated bleeding risk despite the patient not meeting standard dose‑reduction criteria?
I suddenly woke up extremely dizzy—what immediate steps should I take and when should I seek emergency care?
How can I differentiate a post‑viral cough from a protracted bacterial bronchial infection?
What is the first‑line antibiotic of choice for Burkholderia (including Burkholderia cepacia complex) and Stenotrophomonas maltophilia infections?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.